Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats. Focus on organ function and endothelin levels

Thrombosis and Haemostasis

Volumn 93, Issue 4, 2005, Pages 724-728

  Asakura, Hidesaku ^a   Asamura, Risa ^a   Ontachi, Yasuo ^a   Hayashi, Tomoe ^a   Omote, Mika ^a   Arahata, Masahisa ^a   Kadohira, Yasuko ^a   Maekawa, Mio ^a   Yamazaki, Masahide ^a   Morishita, Eriko ^a   Yoshida, Tomotaka ^a   Miyamoto, Ken Ichi ^a   Nakao, Shinji ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

DIC; Endothelin; Fibrinolysis; Urokinase

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; D DIMER; ENDOTHELIN; FIBRINOGEN; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR; SODIUM CHLORIDE; THROMBIN ANTITHROMBIN COMPLEX; UROKINASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; DRUG MEGADOSE; FIBRIN DEPOSITION; FIBRINOLYSIS; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; THROMBOCYTE COUNT; VASOCONSTRICTION;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DISSEMINATED INTRAVASCULAR COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELINS; FIBRINOLYSIS; LIPOPOLYSACCHARIDES; MALE; MULTIPLE ORGAN FAILURE; RATS; RATS, WISTAR; THROMBOLYTIC THERAPY; URINARY PLASMINOGEN ACTIVATOR;

EID: 20144386914     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-07-0422     Document Type: Article

References (32)

1. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-92.
2. Bick RL. Disseminated intravascular coagulation: pathophysiological mechanisms and manifestations. Semin Thromb Hemost 1998; 24: 3-18.
3. Toh CH, Dennis M. Disseminated intravascular coagulation: old disease, new hope. Br Med J 2003; 327: 974-7.
4. Takahashi H, Tatewaki W, Wada K, et al. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol 1990; 33: 90-5.
5. Asakura H, Jokaji H, Saito M, et al. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Blood Coagul Fibrinolysis 1994; 5: 829-32.
6. Matsuda T, et al. Changes in levels of t-PA and alpha 2PI-plasmin complex in plasma in patients with DIC. Thromb Res 1988; Suppl 8: 143-51.
7. Dombret H, et al. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy. Leukemia 1995; 9: 19-24.
8. Paramo JA, Fernandez Diaz FJ, et al. Plasminogen activator inhibitor activity in bacterial infection. Thromb Haemost 1988; 59: 451-4.
9. Levi M, et al. Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis 2003; 16: 43-7.
10. Asakura H, et al. Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats. Crit Care Med 2002; 30: 161-4.
11. Asakura H, et al. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats. Blood Coagul Fibrinolysis 2003; 14: 221-8.
12. Collen D, Lijnen HR: Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Thromb Haemost 1995; 74: 167-71.
13. Levin ER: Endothelins. N Engl J Med 1995; 333: 356-63.
14. Ishibashi M, Saito K, Watanobe K, et al. Plasma endothelin-1 levels in patients with disseminated intravascular coagulation. N Engl J Med 1991; 324: 1516-7.
15. Asakura H, Jokaji H, Saito M, et al. Role of endothelin in disseminated intravascular coagulation. Am J Hematol 1992; 41: 71-5.
16. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-5.
17. Wanecek M, et al. The endothelin system in septic and endotoxin shock. Eur J Pharmacol 2000; 407: 1-15.
18. Asakura H, et al. Induction of vasoactive substances differs in LPS-induced and TF-induced DIC models in rats. Thromb Haemost 2002; 88: 663-7.
19. Pelzer H, et al. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59: 101-6.
20. Suzuki N, Matsumoto H, Kitada C, et al. A sensitive sandwich-enzyme immunoassay for human endothelin. J Immunol Methods 1989; 118: 245-50.
21. Kawasaki H, Hayashi K, Awai M. Disseminated intravascular coagulation (DIC). Immunohistochemical study of fibrin-related materials (FRMs) in renal tissues. Acta Pathol Jpn 1987; 37: 77-84.
22. Bick RL, Baker WF. Diagnostic efficacy of the D-dimer assay in disseminated intravascular coagulation (DIC). Thromb Res 1992; 65: 785-90.
23. Taylor FB Jr, et al. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-30.
24. Kaddoura S, Curzen NP, Evans TW, et al. Tissue expression of endothelin-1 mRNA in endotoxaemia. Biochem Biophys Res Commun 1996; 218: 641-7.
25. Suga Y, Asakura H, Yoshida T, et al. Relationship between endothelin and the pathophysiology of tissue factor-induced and lipopolysaccharide-induced disseminated intravascular coagulation in rats: a study examining the effect of an endothelin receptor antagonist. Blood Coagul Fibrinolysis 2004; 15: 593-8.
26. Lechleitner P, Genser N, Mair J, et al. Plasma immunoreactive endothelin in the acute and subacute phases of myocardial infarction in patients undergoing fibrinolysis. Clin Chem 1993; 39: 955-9.
27. Battistelli S, et al. Behavior of circulating endothelin-1 in a group of patients with acute myocardial infarction. Angiology 1999; 50: 629-38.
28. Yamada Y, Yokota M. Direct interactions of plasminogen activators with human aortic and pulmonary artery endothelial cells in vitro: implications for thrombolytic therapy. J Cardiovasc Pharmacol 1996; 27: 629-35.
29. Schnermann JB, Zhu XL, Shu X, et al. Regulation of endothelin production and secretion in cultured collecting duct cells by endogenous transforming growth factor-beta. Endocrinology 1996; 137: 5000-8.
30. Schneider J. Fibrin-specific lysis of microthrombosis in endotoxemic rats by saruplase. Thromb Res 1993; 72: 71-82.
31. Paloma MJ, et al. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality. Thromb Haemost 1995; 74: 1578-82.
32. Munoz MC, et al. Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits. Br J Haematol 1999; 105: 117-21.